Monoclonal antibodies primed to become potent immune weapons against cancer
Friday, March 20, 2009 - 12:35
in Health & Medicine
New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today, says a researcher at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center in the March 21 issue of the Lancet.
Read the whole article on Physorg
More from Physorg
Related
- Lombardi research: Monoclonal antibodies primed to become potent immune weapons against cancerFri, 20 Mar 2009, 11:04:24 EDT
- Antibody targeting of glioblastoma shows promise in preclinical tests, say Lombardi researchersFri, 31 Jul 2009, 10:00:06 EDT
- Method for fast human antibodies against flu could find broad useWed, 30 Apr 2008, 17:00:25 EDT
- Scientists identify human monoclonal antibodies effective against bird, seasonal flu virusesSun, 22 Feb 2009, 13:29:20 EST
- Antibody gives cancer the recognition it deservesWed, 22 Apr 2009, 15:16:09 EDT